| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/16/2003 | CN1429581A Liquid medicine for treating postpartum fever |
| 07/16/2003 | CN1429574A Capsule for treating hepatitis B |
| 07/16/2003 | CN1429558A Mannosan peptide injection and its preparation and use method |
| 07/16/2003 | CN1429555A Adfuwei ester soft capsule and its preparation method |
| 07/16/2003 | CN1429554A Compound beri-beri ointment |
| 07/16/2003 | CN1429550A Matrine enteric coatel tablet and its preparation method |
| 07/16/2003 | CN1429549A Matrine capsule and its preparation method |
| 07/16/2003 | CN1114690C Papilloma pseudovirus and process for preparing same |
| 07/16/2003 | CN1114608C Novel camptothecine analogues, prepn. method therefor, use thereof, and pharmaceutical compositions contg. same |
| 07/16/2003 | CN1114607C Carbostyril carboxylic acid derivatives |
| 07/16/2003 | CN1114604C Bicyclic aryl carboxamides and their therapeutic use |
| 07/16/2003 | CN1114447C Pharmaceutical antiviral compsn. comprising glycyrrhizic acid and at least one protein endowed with activiral activity |
| 07/16/2003 | CN1114441C Compound tree peony injection |
| 07/16/2003 | CN1114436C Pharmaceutical and cosmetic formulations with antimicrobial activity |
| 07/16/2003 | CN1114417C Medicine for treating fungus diseases |
| 07/16/2003 | CN1114415C Medicine for curing enteritis and bacillary dy sentery |
| 07/16/2003 | CN1114412C Medicine for treating epidemic poultry and animal disease |
| 07/16/2003 | CN1114402C Isothiazolones compound, preparation containing them and its use |
| 07/15/2003 | US6593461 Isolated DNA of given nucleotide sequence which encodes an amino acid sequence; hybridization; use in diagnosing, preventing and treating gastrointestinal disorders |
| 07/15/2003 | US6593366 Ionic polymers as anti-infective agents |
| 07/15/2003 | US6593360 The invention relates to novel 15-membered 8a- and 9a-lactams from the class of 6-O-methyl-erythromycin A of general formula their pharmaceutically acceptable addition salts with inorganic or organic acids and their hydrates, to |
| 07/15/2003 | US6593359 Use of a RAR-γ-specific agonist ligand for increasing the rate of apoptosis |
| 07/15/2003 | US6593357 Treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. |
| 07/15/2003 | US6593356 The present invention relates to the synthesis of a new class of indeno(1,2-c)pyrazol-4-ones of formula (I): that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-7 and the |
| 07/15/2003 | US6593352 2-phenylalkylaminobenzoic acid containing substituted benzylsufamoyl group; useful for treating cardiovascular disorders, and for preserving or storing a transplant for surgery |
| 07/15/2003 | US6593347 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 07/15/2003 | US6593339 Use of compounds as antibacterial agents |
| 07/15/2003 | US6593337 Tricyclic compounds useful as HIV reverse transcriptase inhibitors |
| 07/15/2003 | US6593325 Method for the treatment of anxiety which comprises administering to a patient in need of such treatment an effective amount of the compound of claim 1 or a pharmaceutically acceptable salt thereof. |
| 07/15/2003 | US6593319 Fusidic acid derivatives |
| 07/15/2003 | US6593313 Co-administration of a prostaglandin and an androgenic agent in the treatment of female sexual dysfunction |
| 07/15/2003 | US6593302 Macrolide antiinfective agents |
| 07/15/2003 | US6593292 Amidine and/or guanidine substituted peptoid and drug conjugates for drug delivery across endo/epithelial tissue |
| 07/15/2003 | US6593291 Inhibition of endothelial cell proliferation inhibits neovascularization |
| 07/15/2003 | US6593134 Propagation of chicken infectious anemia virus; prepare nutrient broth, inoculate with cells infected with marek's disease, propagate, recover infected cells |
| 07/15/2003 | US6593132 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 07/15/2003 | US6592907 Treating an eye infections; cleansing a contact lens in place on an eye |
| 07/15/2003 | US6592901 Highly compressible ethylcellulose for tableting |
| 07/15/2003 | US6592896 Medicinal composition and method of using it |
| 07/15/2003 | US6592894 Hydrogel-isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/15/2003 | US6592890 Conveyance of anti-infective activity to wound dressings |
| 07/15/2003 | US6592877 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/15/2003 | US6592876 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 07/15/2003 | US6592875 Borrelia burgdorferi antigen at subvaccine level to alleviate symptoms |
| 07/15/2003 | US6592873 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids |
| 07/15/2003 | US6592871 Partial sequences of the C-100-3 and env/core with C-regions |
| 07/15/2003 | US6592868 Produced by hybridoma having ATCC Accession Number HB 10916 |
| 07/15/2003 | US6592860 Composition and applicator for topical substance delivery |
| 07/15/2003 | CA2286013C Process for making a butylthio-isoquinoline and intermediates therefor |
| 07/15/2003 | CA2245938C Combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection |
| 07/15/2003 | CA2077562C Diastereomers of 1-(isopropoxycarbonyloxy) ethyl 3-cephem-4-carboxylate and processes for their preparation |
| 07/14/2003 | WO2003059878A2 Thieno (3, 2-b) pyridones as antiviral compounds |
| 07/14/2003 | CA2472960A1 Thieno (3, 2-b) pyridones as antiviral compounds |
| 07/10/2003 | WO2003056012A1 A system for stable expression of sirnas in mammalian cells |
| 07/10/2003 | WO2003056008A1 Regulation of the expression of bacterial motility-associated genes |
| 07/10/2003 | WO2003055994A1 Hxhv virus, nucleic material, peptide material and uses |
| 07/10/2003 | WO2003055987A1 Novel lactobacillus sp. strain and use thereof |
| 07/10/2003 | WO2003055980A2 Il-17 like molecules and uses thereof |
| 07/10/2003 | WO2003055918A1 Negatively charged polysaccharide derivable from aloe vera |
| 07/10/2003 | WO2003055915A2 Human netrin receptor and uses thereof |
| 07/10/2003 | WO2003055913A2 Secreted protein |
| 07/10/2003 | WO2003055912A2 Secreted proteins |
| 07/10/2003 | WO2003055911A2 Cystine-knot fold protein |
| 07/10/2003 | WO2003055906A1 Modified bacterial surface layer proteins |
| 07/10/2003 | WO2003055896A2 Anti-viral 7-deaza l-nucleosides |
| 07/10/2003 | WO2003055891A1 Streptogramin derivatives, preparation thereof and compositions containing same |
| 07/10/2003 | WO2003055882A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 07/10/2003 | WO2003055876A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 07/10/2003 | WO2003055868A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 07/10/2003 | WO2003055865A1 Quinazolinone derivative |
| 07/10/2003 | WO2003055863A1 Novel alkansulfonamides as endothelin antagonists |
| 07/10/2003 | WO2003055502A1 Immunoglobulin composition |
| 07/10/2003 | WO2003055498A1 Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std) |
| 07/10/2003 | WO2003055456A1 Stable surfactant compositions for suspending components |
| 07/10/2003 | WO2003055447A2 Heterocyclic acridone inhibitors of impdh enzyme |
| 07/10/2003 | WO2003055442A2 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |
| 07/10/2003 | WO2003050119A3 Urea substituted imidazopyridines |
| 07/10/2003 | WO2003041694A3 Use of compounds comprising iodine, strontium and ascorbic acid as well as either bismuth, zinc or potassium in the treatment of aids |
| 07/10/2003 | WO2003023015A3 Method for expression of small antiviral rna molecules within a cell |
| 07/10/2003 | WO2003015698A3 Application of lipid vehicles and use for drug delivery |
| 07/10/2003 | WO2003010140A3 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 07/10/2003 | WO2003006440A8 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound |
| 07/10/2003 | WO2003004511A3 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 07/10/2003 | WO2002092625A3 Moraxella(branhamella) catarrhalis antigens |
| 07/10/2003 | WO2002083060A3 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs |
| 07/10/2003 | WO2002063008A3 Intracellular signaling molecules |
| 07/10/2003 | WO2002059267A3 Constitutively desensitized g protein-coupled receptors |
| 07/10/2003 | WO2002046409A3 Proteins and nucleic acids encoding same |
| 07/10/2003 | WO2002043570A3 METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES |
| 07/10/2003 | WO2002036159A3 Immunoprotective recombinant antigen from anaplasma marginale, vaccine compositions and methods of use |
| 07/10/2003 | WO2002028408A9 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 07/10/2003 | WO2002018581A3 G-protein coupled receptors |
| 07/10/2003 | WO2002000730A9 Pd-l2 molecules: novel pd-1 ligands and uses therefor |
| 07/10/2003 | WO2001098269A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 07/10/2003 | WO2001098248A3 Hiv integrase inhibitors |
| 07/10/2003 | WO2001096297A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 07/10/2003 | WO2001089364A9 Hcv variants |
| 07/10/2003 | US20030131363 Controlling the activation of genetic translation, cell proliferation, especially hematopoietic cells; drug screening for compounds which alter the activity of the kinase; thalassemias, sickle cell disease, unstable hemoglobins |
| 07/10/2003 | US20030130518 They induce the biosynthesis of various cytokines and are useful in the treatment of viral and neoplastic diseases. |
| 07/10/2003 | US20030130515 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |